Advisor Net Financial, Inc Incyte Corp Transaction History

Advisor Net Financial, Inc

$1.46 Billion
Q2 2025

A detailed history of Advisor Net Financial, Inc transactions in Incyte Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 3,021 shares of INCY stock, worth $236,816. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,021

Previous 3,012 0.3%

Holding current value

$236,816

Previous $182,000 12.64%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	BUY	$55.17 - $71.22 $496 - $640	9 Added 0.3%	3,021 $205,000
Q1 2025 Apr 07, 2025	SELL	$60.0 - $75.26 $7,380 - $9,256	-123 Reduced 3.92%	3,012 $182,000
Q4 2024 Jan 13, 2025	SELL	$65.08 - $83.38 $2,212 - $2,834	-34 Reduced 1.07%	3,135 $216,000
Q3 2024 Oct 15, 2024	SELL	$57.33 - $68.61 $20,352 - $24,356	-355 Reduced 10.07%	3,169 $209,000
Q2 2024 Jul 16, 2024	SELL	$51.18 - $63.75 $25,487 - $31,747	-498 Reduced 12.38%	3,524 $213,000
Q1 2024 Apr 12, 2024	BUY	$56.55 - $66.59 $565 - $665	10 Added 0.25%	4,022 $229,000
Q4 2023 Jan 19, 2024	BUY	$52.16 - $64.19 $1,877 - $2,310	36 Added 0.91%	4,012 $251,000
Q3 2023 Oct 12, 2023	SELL	$57.77 - $65.93 $1,270 - $1,450	-22 Reduced 0.55%	3,976 $229,000
Q2 2023 Jul 14, 2023	BUY	$60.95 - $75.51 $853 - $1,057	14 Added 0.35%	3,998 $248,000
Q1 2023 Apr 28, 2023	SELL	$70.23 - $86.01 $11,377 - $13,933	-162 Reduced 3.91%	3,984 $287,000
Q4 2022 Jan 13, 2023	BUY	$67.18 - $84.11 $1,612 - $2,018	24 Added 0.58%	4,146 $0
Q3 2022 Oct 04, 2022	BUY	$66.18 - $82.86 $330 - $414	5 Added 0.12%	4,122 $275,000
Q2 2022 Jul 07, 2022	BUY	$66.18 - $83.18 $992 - $1,247	15 Added 0.37%	4,117 $313,000
Q1 2022 Apr 14, 2022	BUY	$66.02 - $79.71 $4,291 - $5,181	65 Added 1.61%	4,102 $326,000
Q3 2021 Oct 15, 2021	BUY	$68.67 - $84.02 $8,583 - $10,502	125 Added 3.2%	4,037 $278,000
Q2 2021 Jul 06, 2021	BUY	$79.87 - $87.53 $4,392 - $4,814	55 Added 1.43%	3,912 $329,000
Q3 2019 Oct 23, 2019	SELL	$72.82 - $86.52 $15,510 - $18,428	-213 Reduced 5.23%	3,857 $286,000
Q2 2019 Jul 15, 2019	SELL	$73.52 - $88.7 $49,478 - $59,695	-673 Reduced 14.19%	4,070 $346,000
Q4 2017 Feb 27, 2018	BUY	$93.56 - $116.6 $443,755 - $553,033	4,743	4,743 $449,000

Others Institutions Holding INCY

# of Institutions

707

Shares Held

195M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Incyte Corp Transaction History